Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 618-780-1 | CAS number: 916809-14-8
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Toxicological Summary
- Administrative data
- Workers - Hazard via inhalation route
- Workers - Hazard via dermal route
- Workers - Hazard for the eyes
- Additional information - workers
- General Population - Hazard via inhalation route
- General Population - Hazard via dermal route
- General Population - Hazard via oral route
- General Population - Hazard for the eyes
- Additional information - General Population
Administrative data
Workers - Hazard via inhalation route
Systemic effects
Long term exposure
- Hazard assessment conclusion:
- DNEL (Derived No Effect Level)
- Value:
- 0.99 mg/m³
- Most sensitive endpoint:
- repeated dose toxicity
- Route of original study:
- Oral
DNEL related information
- DNEL derivation method:
- ECHA REACH Guidance
- Overall assessment factor (AF):
- 45
- Dose descriptor starting point:
- NOAEL
- Value:
- 18.1 mg/kg bw/day
- Modified dose descriptor starting point:
- NOAEC
- Value:
- 44.68 mg/m³
- Explanation for the modification of the dose descriptor starting point:
The NOAEL from an oral repeated dose study with rats conducted according to OECD TG 407 (BASF, 2009) was identified as the appropriate starting point for DNEL derivation for long-term exposure following inhalation. The NOAEL for general, systemic toxicity of the test substance was 18.1 mg/kg bw/day for rats based on salivation and slight effects on the body weight at the next higher dose level of 86 mg/kg bw/day in male rats only.
The NOAEL of 18.1 mg/kg bw/day thus was considered appropriate as point of departure for DNEL derivation. This point of departure was modified to get the corrected starting point for DNEL derivation. As a first step, route-to-route extrapolation was performed as recommended in the “Guidance on information requirements and chemical safety assessment, Chapter R.8, p. 26 f.:
The oral rat NOAEL was converted into the inhalative human NOAEC corrected for differences between the exposure duration of 5 days per week in comparison to 7 days per week, the 8-hour standard inhalation volume of rats versus humans, and for differences between the 8-hour inhalation volume of workers in rest versus workers in light activity, by multiplying with the corresponding factors (x 5/7 x 1/0.38 m³/kg/day x 6.7 m³/10 m³). The resulting corrected starting point for inhalation DNEL derivation for workers is equal to 44.68 mg/m³.
- AF for dose response relationship:
- 1
- Justification:
- Default value
- AF for differences in duration of exposure:
- 6
- Justification:
- Default value: subacute to chronic
- AF for interspecies differences (allometric scaling):
- 1
- Justification:
- Respiratory interspecies differences are fully covered by the factors used for route to route extrapolation
- AF for other interspecies differences:
- 2.5
- Justification:
- Default value
- AF for intraspecies differences:
- 3
- Justification:
- Systemic effects in the repeated dose study with rats were minimal and restricted to general systemic toxicity (effects on body weight, food consumption, salivation) and only present in males (LOAEL: 86 mg/kg bw/day) at the next higher dose level. Therefore an intraspecies factor of 3 is considered to be sufficient.
- AF for the quality of the whole database:
- 1
- Justification:
- Default value
- AF for remaining uncertainties:
- 1
- Justification:
- Default value
Acute/short term exposure
- Hazard assessment conclusion:
- no hazard identified
DNEL related information
Local effects
Long term exposure
- Hazard assessment conclusion:
- no hazard identified
Acute/short term exposure
- Hazard assessment conclusion:
- no hazard identified
DNEL related information
Workers - Hazard via dermal route
Systemic effects
Long term exposure
- Hazard assessment conclusion:
- DNEL (Derived No Effect Level)
- Value:
- 1.4 mg/kg bw/day
- Most sensitive endpoint:
- repeated dose toxicity
- Route of original study:
- Oral
DNEL related information
- DNEL derivation method:
- ECHA REACH Guidance
- Overall assessment factor (AF):
- 180
- Dose descriptor starting point:
- NOAEL
- Value:
- 18.1 mg/kg bw/day
- Modified dose descriptor starting point:
- NOAEL
- Value:
- 253.4 mg/kg bw/day
- Explanation for the modification of the dose descriptor starting point:
The NOAEL from an oral repeated dose study with rats conducted according to OECD TG 407 (BASF, 2009) was identified as the appropriate starting point for DNEL derivation for long-term exposure following dermal application. The NOAEL for general, systemic toxicity of the test substance was 18.1 mg/kg bw/day for rats based on salivation and slight effects on the body weight at the next higher dose level of 86 mg/kg bw/day in male rats only.
The NOAEL of 18.1 mg/kg bw/day thus was considered appropriate as point of departure for DNEL derivation. This point of departure was modified to get the corrected starting point for DNEL derivation. As a first step, route-to-route extrapolation was performed as recommended in the “Guidance on information requirements and chemical safety assessment, Chapter R.8, p. 26 f.:
The oral rat NOAEL was converted into the dermal human NOAEL corrected for differences between the exposure duration of 5 days per week in comparison to 7 days per week, and for differences between the oral and dermal absorption rate (calculated with DermWin as "very low"; furthermore no clinical signs were observed in the acute dermal toxicity study in comparison to the acute oral toxicity study), by multiplying with the corresponding factors (x 5/7 x 100/10). The resulting corrected starting point for dermal DNEL derivation for workers is equal to 253.4 mg/kg bw/day.
- AF for dose response relationship:
- 1
- Justification:
- Default value
- AF for differences in duration of exposure:
- 6
- Justification:
- Default value: subacute to chronic
- AF for interspecies differences (allometric scaling):
- 4
- Justification:
- Default value: rat to human
- AF for other interspecies differences:
- 2.5
- Justification:
- Default value
- AF for intraspecies differences:
- 3
- Justification:
- Systemic effects in the repeated dose study with rats were minimal and restricted to general systemic toxicity (effects on body weight, food consumption, salivation) and only present in males (LOAEL: 86 mg/kg bw/day) at the next higher dose level. Therefore an intraspecies factor of 3 is considered to be sufficient.
- AF for the quality of the whole database:
- 1
- Justification:
- Default value
- AF for remaining uncertainties:
- 1
- Justification:
- Default value
Acute/short term exposure
- Hazard assessment conclusion:
- no hazard identified
DNEL related information
Local effects
Long term exposure
- Hazard assessment conclusion:
- no hazard identified
Acute/short term exposure
- Hazard assessment conclusion:
- no hazard identified
Workers - Hazard for the eyes
Local effects
- Hazard assessment conclusion:
- low hazard (no threshold derived)
Additional information - workers
General Population - Hazard via inhalation route
Systemic effects
Long term exposure
- Hazard assessment conclusion:
- DNEL (Derived No Effect Level)
- Value:
- 0.209 mg/m³
- Most sensitive endpoint:
- repeated dose toxicity
- Route of original study:
- Oral
DNEL related information
- DNEL derivation method:
- ECHA REACH Guidance
- Overall assessment factor (AF):
- 75
- Dose descriptor starting point:
- NOAEL
- Value:
- 18.1 mg/kg bw/day
- Modified dose descriptor starting point:
- NOAEC
- Value:
- 15.74 mg/m³
- Explanation for the modification of the dose descriptor starting point:
The NOAEL from an oral repeated dose study with rats conducted according to OECD TG 407 (BASF, 2009) was identified as the appropriate starting point for DNEL derivation for long-term exposure following inhalation. The NOAEL for general, systemic toxicity of the test substance was 18.1 mg/kg bw/day for rats based on salivation and slight effects on the body weight at the next higher dose level of 86 mg/kg bw/day in male rats only.
The NOAEL of 18.1 mg/kg bw/day thus was considered appropriate as point of departure for DNEL derivation. This point of departure was modified to get the corrected starting point for DNEL derivation. As a first step, route-to-route extrapolation was performed as recommended in the “Guidance on information requirements and chemical safety assessment, Chapter R.8, p. 26 f.:
The oral rat NOAEL was converted into the inhalative human NOAEC corrected for differences between the 24 -hour standard inhalation volume of rats versus humans by multiplying with the corresponding factor (x 1/1.15 m³/kg/day). The resulting corrected starting point for inhalation DNEL derivation for general population is equal to 15.74 mg/m³.
- AF for dose response relationship:
- 1
- Justification:
- Default value
- AF for differences in duration of exposure:
- 6
- Justification:
- Default value: subacute to chronic
- AF for interspecies differences (allometric scaling):
- 1
- Justification:
- Respiratory interspecies differences are fully covered by the factors used for route to route extrapolation
- AF for other interspecies differences:
- 2.5
- Justification:
- Default value
- AF for intraspecies differences:
- 5
- Justification:
- Systemic effects on the repeated dose study with rats were minimal and restricted to general systemic toxicity (effects on body weight, food consumption, salivation) and only present in males (LOAEL: 86 mg/kg bw/day) at the next higher dose level. Therefore, an intraspecies factor of 5 is considered to be sufficient.
- AF for the quality of the whole database:
- 1
- Justification:
- Default value
- AF for remaining uncertainties:
- 1
- Justification:
- Default value
Acute/short term exposure
- Hazard assessment conclusion:
- no hazard identified
DNEL related information
Local effects
Long term exposure
- Hazard assessment conclusion:
- no hazard identified
Acute/short term exposure
- Hazard assessment conclusion:
- no hazard identified
DNEL related information
General Population - Hazard via dermal route
Systemic effects
Long term exposure
- Hazard assessment conclusion:
- DNEL (Derived No Effect Level)
- Value:
- 0.6 mg/kg bw/day
- Most sensitive endpoint:
- repeated dose toxicity
- Route of original study:
- Oral
DNEL related information
- DNEL derivation method:
- ECHA REACH Guidance
- Overall assessment factor (AF):
- 300
- Dose descriptor starting point:
- NOAEL
- Value:
- 18.1 mg/kg bw/day
- Modified dose descriptor starting point:
- NOAEL
- Value:
- 181 mg/kg bw/day
- Explanation for the modification of the dose descriptor starting point:
The NOAEL from an oral repeated dose study with rats conducted according to OECD TG 407 (BASF, 2009) was identified as the appropriate starting point for DNEL derivation for long-term exposure following dermal application. The NOAEL for general, systemic toxicity of the test substance was 18.1 mg/kg bw/day for rats based on salivation and slight effects on the body weight at the next higher dose level of 86 mg/kg bw/day in male rats only.
The NOAEL of 18.1 mg/kg bw/day thus was considered appropriate as point of departure for DNEL derivation. This point of departure was modified to get the corrected starting point for DNEL derivation. As a first step, route-to-route extrapolation was performed as recommended in the “Guidance on information requirements and chemical safety assessment, Chapter R.8, p. 26 f.:
The oral rat NOAEL was converted into the dermal human NOAEL corrected for differences between the oral and dermal absorption rate (calculated with DermWin as "very low", furthermore no clinical signs were observed in the acute dermal toxicity study in comparison to the acute oral toxicity study), by multiplying with the corresponding factor (x 100/10). The resulting corrected starting point for dermal DNEL derivation for general population is equal to 181.0 mg/kg bw/day.
- AF for dose response relationship:
- 1
- Justification:
- Default value
- AF for differences in duration of exposure:
- 6
- Justification:
- subacute to chronic
- AF for interspecies differences (allometric scaling):
- 4
- Justification:
- rat to human
- AF for other interspecies differences:
- 2.5
- Justification:
- Default value
- AF for intraspecies differences:
- 5
- Justification:
- Systemic effects on the repeated dose study with rats were minimal and restricted to general systemic toxicity (effects on body weight, food consumption, salivation) and only present in males (LOAEL: 86 mg/kg bw/day) at the next higher dose level. Therefore, an intraspecies factor of 5 is considered to be sufficient.
- AF for the quality of the whole database:
- 1
- Justification:
- Default value
- AF for remaining uncertainties:
- 1
- Justification:
- Default value
Acute/short term exposure
- Hazard assessment conclusion:
- no hazard identified
DNEL related information
Local effects
Long term exposure
- Hazard assessment conclusion:
- no hazard identified
Acute/short term exposure
- Hazard assessment conclusion:
- no hazard identified
General Population - Hazard via oral route
Systemic effects
Long term exposure
- Hazard assessment conclusion:
- DNEL (Derived No Effect Level)
- Value:
- 0.06 mg/kg bw/day
- Most sensitive endpoint:
- repeated dose toxicity
- Route of original study:
- Oral
DNEL related information
- DNEL derivation method:
- ECHA REACH Guidance
- Overall assessment factor (AF):
- 300
- Dose descriptor starting point:
- NOAEL
- Value:
- 18.1 mg/kg bw/day
- Modified dose descriptor starting point:
- NOAEL
- Value:
- 18.1 mg/kg bw/day
- Explanation for the modification of the dose descriptor starting point:
The NOAEL from an oral repeated dose study with rats conducted according to OECD TG 407 (BASF, 2009) was identified as the appropriate starting point for DNEL derivation for long-term exposure following oral administration. The NOAEL for general, systemic toxicity of the test substance was 18.1 mg/kg bw/day for rats based on salivation and slight effects on the body weight at the next higher dose level of 86 mg/kg bw/day in male rats only.
The NOAEL of 18.1 mg/kg bw/day thus was considered appropriate as point of departure for DNEL derivation.
- AF for dose response relationship:
- 1
- Justification:
- Default value
- AF for differences in duration of exposure:
- 6
- Justification:
- subacute to chronic
- AF for interspecies differences (allometric scaling):
- 4
- Justification:
- rat to human
- AF for other interspecies differences:
- 2.5
- Justification:
- Default value
- AF for intraspecies differences:
- 5
- Justification:
- Systemic effects on the repeated dose study with rats were minimal and restricted to general systemic toxicity (effects on body weight, food consumption, salivation) and only present in males (LOAEL: 86 mg/kg bw/day) at the next higher dose level. Therefore, an intraspecies factor of 5 is considered to be sufficient.
- AF for the quality of the whole database:
- 1
- Justification:
- Default value
- AF for remaining uncertainties:
- 1
- Justification:
- Default value
Acute/short term exposure
- Hazard assessment conclusion:
- no hazard identified
DNEL related information
General Population - Hazard for the eyes
Local effects
- Hazard assessment conclusion:
- low hazard (no threshold derived)
Additional information - General Population
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.